Pequin P, Manfredi S, Quentin V, Heresbach D, Boyer J, Siproudhis L, Bretagne J-F
Service des Maladies de l'Appareil Digestif, hôpital Pontchaillou, Rennes, France.
Aliment Pharmacol Ther. 2007 Jul 15;26(2):277-82. doi: 10.1111/j.1365-2036.2007.03359.x.
To evaluate colorectal cancer risk among patients with sporadic duodenal neoplasia using a case-control protocol.
Cases were 35 patients referred for the management of sporadic duodenal adenoma and who underwent colonoscopy. Colonoscopy findings among cases were compared with those from a control group matched for age and sex (two controls per case) without duodenal adenoma. Colonoscopy findings were categorized as adenoma, advanced adenoma, cancer or advanced neoplasia. The two groups were compared using the chi-squared test. Odds ratio and 95% confidence intervals were calculated.
Colorectal adenoma was present in 31% of cases vs. 24% of controls, advanced neoplasia in 29% vs. 4%, advanced adenoma in 23% vs. 3% and adenocarcinoma in 6% vs. 1%. The relative risks of advanced colorectal adenoma and advanced colorectal neoplasia in cases were 10.1 (95% CI: 1.8-100.1, P = 0.003) and 8.9 (95% CI: 2.1-53.3, P = 0.001), respectively.
The relative risk of advanced colorectal adenoma and advanced neoplasia in cases was nine- to 10-fold that among controls. Patients with sporadic duodenal adenoma represent a high-risk group for advanced colorectal neoplasia and should therefore undergo complete colonoscopy.
采用病例对照研究方案评估散发性十二指肠肿瘤患者患结直肠癌的风险。
病例组为35例因散发性十二指肠腺瘤接受治疗并接受结肠镜检查的患者。将病例组的结肠镜检查结果与年龄和性别匹配的对照组(每例病例匹配两名对照)进行比较,对照组无十二指肠腺瘤。结肠镜检查结果分为腺瘤、高级别腺瘤、癌或高级别肿瘤。采用卡方检验对两组进行比较。计算比值比和95%置信区间。
病例组中31%存在结直肠腺瘤,对照组为24%;高级别肿瘤病例组为29%,对照组为4%;高级别腺瘤病例组为23%,对照组为3%;腺癌病例组为6%,对照组为1%。病例组中高级别结直肠腺瘤和高级别结直肠肿瘤的相对风险分别为10.1(95%置信区间:1.8 - 100.1,P = 0.003)和8.9(95%置信区间:2.1 - 53.3,P = 0.001)。
病例组中高级别结直肠腺瘤和高级别肿瘤的相对风险是对照组的9至10倍。散发性十二指肠腺瘤患者是高级别结直肠肿瘤的高危人群,因此应接受完整的结肠镜检查。